miRNA-27a is involved in the knockdown of RKIP which contributes to a mesenchymal phenotype with the corresponding upregulation of vimentin and downregulation of E-cadherin, both being important in cancer progression and chemotherapy resistance [172]. The gene discussed is CDH1; the disease is cancer.